These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25556151)

  • 1. Antitumor effects of hyaluronan inhibition in desmoid tumors.
    Briggs A; Rosenberg L; Buie JD; Rizvi H; Bertagnolli MM; Cho NL
    Carcinogenesis; 2015 Feb; 36(2):272-9. PubMed ID: 25556151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.
    Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K
    Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer.
    Paiva P; Van Damme MP; Tellbach M; Jones RL; Jobling T; Salamonsen LA
    Gynecol Oncol; 2005 Aug; 98(2):193-202. PubMed ID: 15936804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of hyaluronan, HAS1-2, and HYAL1-2 in oral lichen planus.
    Siponen M; Kullaa A; Nieminen P; Salo T; Pasonen-Seppänen S
    J Oral Pathol Med; 2015 Jul; 44(6):401-9. PubMed ID: 25421996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive CD44-dependent hyaluronan coats on human bone marrow-derived mesenchymal stem cells produced by hyaluronan synthases HAS1, HAS2 and HAS3.
    Qu C; Rilla K; Tammi R; Tammi M; Kröger H; Lammi MJ
    Int J Biochem Cell Biol; 2014 Mar; 48():45-54. PubMed ID: 24406795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
    Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
    Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells.
    Saito T; Tamura D; Nakamura T; Makita Y; Ariyama H; Komiyama K; Yoshihara T; Asano R
    Oncol Rep; 2013 Jan; 29(1):335-42. PubMed ID: 23124556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.
    Piccioni F; Malvicini M; Garcia MG; Rodriguez A; Atorrasagasti C; Kippes N; Piedra Buena IT; Rizzo MM; Bayo J; Aquino J; Viola M; Passi A; Alaniz L; Mazzolini G
    Glycobiology; 2012 Mar; 22(3):400-10. PubMed ID: 22038477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
    Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
    Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.
    Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y
    Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
    Udabage L; Brownlee GR; Nilsson SK; Brown TJ
    Exp Cell Res; 2005 Oct; 310(1):205-17. PubMed ID: 16125700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activity.
    Qin J; Kilkus J; Dawson G
    Biochim Biophys Acta; 2016 Feb; 1861(2):78-90. PubMed ID: 26548718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of hyaluronidase-2 during preimplantation embryo development.
    Marei WF; Salavati M; Fouladi-Nashta AA
    Mol Hum Reprod; 2013 Sep; 19(9):590-9. PubMed ID: 23625939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.
    Tofuku K; Yokouchi M; Murayama T; Minami S; Komiya S
    Int J Oncol; 2006 Jul; 29(1):175-83. PubMed ID: 16773198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukemic cell lines synthesize hyaluronan to avoid senescence and resist chemotherapy.
    Lompardía SL; Papademetrio DL; Mascaró M; Álvarez EM; Hajos SE
    Glycobiology; 2013 Dec; 23(12):1463-76. PubMed ID: 24013961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: relationship with tumor aggressiveness.
    Bertrand P; Courel MN; Maingonnat C; Jardin F; Tilly H; Bastard C
    Int J Cancer; 2005 Jan; 113(2):207-12. PubMed ID: 15386412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.
    Nagase H; Kudo D; Suto A; Yoshida E; Suto S; Negishi M; Kakizaki I; Hakamada K
    Pancreas; 2017 Feb; 46(2):190-197. PubMed ID: 27846148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization.
    Mochimaru H; Takahashi E; Tsukamoto N; Miyazaki J; Yaguchi T; Koto T; Kurihara T; Noda K; Ozawa Y; Ishimoto T; Kawakami Y; Tanihara H; Saya H; Ishida S; Tsubota K
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4410-5. PubMed ID: 19339747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in epidermal hyaluronan metabolism following UVB irradiation.
    Tobiishi M; Sayo T; Yoshida H; Kusaka A; Kawabata K; Sugiyama Y; Ishikawa O; Inoue S
    J Dermatol Sci; 2011 Oct; 64(1):31-8. PubMed ID: 21752603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover.
    Colombaro V; Jadot I; Declèves AE; Voisin V; Giordano L; Habsch I; Flamion B; Caron N
    Acta Histochem; 2015 Jan; 117(1):83-91. PubMed ID: 25468725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.